Novavax


Novavax Achieves Positive Results for COVID-19 Vaccine Candidate NVX-Cov2373 During Trials

Shares of Novavax (NVAX) gained 2.3% on Friday after the company announced that its experimental COVID-19 vaccine candidate, NVX-CoV2373, showed a strong immune …

Novavax Swings to a 1Q Loss; Shares Plunge 9%

Shares of Novavax (NVAX) fell almost 9% on Monday May 10 after the biotechnology company reported a loss in the first quarter. However, …

Novavax’s Production Problems Are Overblown, Says Analyst

Reports of raw materials shortages causing production delays for Novavax’s (NVAX) COVID-19 vaccine forced the company to postpone signing a supply contract with …

Novavax’s COVID-19 Vaccine Is 96.4% Effective In UK Trial; Shares Pop 23%

Shares of Novavax popped almost 23% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine candidate showed to …

Novavax Extends SK Bioscience Partnership For Supply Of 40M COVID-19 Vaccine Doses

Novavax, a biotechnology company, and SK Group’s vaccine subsidiary extended their collaboration and license agreement for the manufacturing of an additional 40 million …

Novavax’s COVID-19 Vaccine Is 89.3% Effective In UK Trial; Shares Pop 27%

Shares of Novavax spiked almost 27% in Thursday’s extended market session after the biotech company announced that its coronavirus vaccine showed to be …

Novavax Executives Bank Profits With Vaccine Trials Still Ongoing – Report

Novavax executives have seized the opportunity to bank profits and capitalize on the 3,000% rally in the stock’s share price as speculators continue …

Novavax Pops 8% On Covid-19 Vaccine Data; Analyst Says Buy Amid Pullback

Shares in Novavax are surging almost 8% in the pre-market session after the biotech company said additional data from the Phase 1/2 clinical …

Novavax Strikes Covid-19 Vaccine Deal With Canada As Investors Take Profits

Novavax reached an agreement in principle with the Government of Canada to supply up to 76 million doses of NVX-CoV2373, its COVID-19 vaccine candidate. Novavax …

Novavax Launches Covid-19 Vaccine Efficacy Trial In South Africa

Late-stage biotech Novavax (NVAX) has announced the beginning of a Phase 2b clinical trial in South Africa to evaluate the efficacy of NVX-CoV2373, Novavax’ COVID-19 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts